PHENERGAN TABLET 50MG Strength
Active ingredient(s) See footnote 8 : Strength PROMETHAZINE HYDROCHLORIDE : 50 MG / TAB · DIN 01937707 · RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9
Health Canada status: CANCELLED POST MARKET
What is PHENERGAN TABLET 50MG?
PHENERGAN TABLET 50MG Strength contains Active ingredient(s) See footnote 8 : Strength PROMETHAZINE HYDROCHLORIDE : 50 MG / TAB. It is listed in the Health Canada Drug Product Database under DIN 01937707, held by RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9, supplied as Tablet for Oral administration. Health Canada currently lists it as cancelled post market, status dated 13-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is PHENERGAN TABLET 50MG called?
The same molecule, PROMETHAZINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Phenergan | Latin | Morocco, South Africa |
| HISTAZINE | Latin | Morocco |
| Prohist | Latin | South Africa |
| Receptozine | Latin | South Africa |
| Lenazine Elixir | Latin | South Africa |
| Phenergan Cream | Latin | South Africa |
| Phensedyl Cough Linctus | Latin | South Africa |
| PROMANTINE SYRUP | Latin | Saudi Arabia |
| PROMETHAZINE HYDROCHLORIDE | Latin | Lebanon |
| Rhinathiol Promethazine | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 01937707 |
|---|---|
| Brand name | PHENERGAN TABLET 50MG |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength PROMETHAZINE HYDROCHLORIDE : 50 MG / TAB |
| Manufacturer | RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9 |
| Strength | Strength |
| Dosage form | Tablet |
| Route of administration | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AD02 PROMETHAZINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 13-Aug-1997 |
| Original market date | 1992-12-31 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01937707 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1937707 |
| Brand name | PHENERGAN TABLET 50MG |
| Active ingredient / INN | Active ingredient(s) See footnote 8 : Strength PROMETHAZINE HYDROCHLORIDE : 50 MG / TAB |
| ATC code | R06AD02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R06 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9 |
Which pack is which?
| Strength on the label | Strength |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R06AD02 PROMETHAZINE. 1 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HISTANTIL TAB 50MG | 50 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 00575186 |
| HISTANTIL TAB 25MG | 25 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00575178 |
| PHENERGAN 50 | Strength | Tablet | COLUMBIA LABORATORIES CANADA INC 36 1111 Flint Road North York Ontario Canada M3J 3C7 | CANCELLED POST MARKET | DIN 02162237 |
| PHENERGAN INJECTABLE 25MG/ML | 25 MG | SOLUTION | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 01927566 |
| PHENERGAN SYRUP 10MG/5ML | Strength | Syrup | RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9 | CANCELLED POST MARKET | DIN 01937693 |
| PHENERGAN TABLET 10MG | Strength | Tablet | RHONE-POULENC RORER CONSUMER INC. 4707 Levy St-Laurent Quebec Canada H4R 2P9 | CANCELLED POST MARKET | DIN 01937723 |
| PHENERGAN TABLET 25MG | 25 MG | TABLET | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02162229 |
| PHENERGAN TABLET 25MG | 25 MG | TABLET | RHONE-POULENC RORER CONSUMER INC. | CANCELLED POST MARKET | DIN 01937715 |
| PMS-PROMETHAZINE SYR 10MG/5ML | 10 MG / 5 ML | SYRUP | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00583979 |
| PROMETHAZINE HCL INJ 28.2MG/ML | 28.2 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00627607 |
Who else supplies PROMETHAZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PROMETHAZINE appears in 29 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PROMETHAZINE cost around the world?
PROMETHAZINE is listed on 5 national price registers Nexara tracks, across 72 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 10 | 49 | 03 Sep 2026 |
| South Africa | single exit price | 7 | 10 | 01 Sep 2026 |
| Saudi Arabia | public | 7 | 7 | 01 Sep 2026 |
| Morocco | PPV (public price) | 2 | 5 | 05 Sep 2026 |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.